COMMUNIQUÉS West-GlobeNewswire

Four SPR® Abstracts Honored with Awards at 24th Annual ASRA Pain Meeting
13/11/2025
CLEVELAND, Nov. 13, 2025 (GLOBE NEWSWIRE) -- SPR will have a significant presence at the upcoming annual ASRA Pain Medicine Meeting in Austin, Texas. A total of eight abstracts featuring the SPR SPRINT ® PNS System will [...]
LiveWorld Reports Third Quarter 2025 Financial Results
13/11/2025
LiveWorld continues to increase its AI investment CAMPBELL, Calif. and NEW YORK, Nov. 13, 2025 (GLOBE NEWSWIRE) -- LiveWorld, Inc. (OTC Markets: LVWD), today announced financial results for third quarter 2025. Q3 2025 [...]
HealthEquity to Enhance Member Experience with Agentic AI
13/11/2025
Nation's Largest HSA Custodian Leverages Parloa’s Advanced AI Technology to Deliver Personalized, Conversational Support for Millions of Members DRAPER, Utah, Nov. 13, 2025 (GLOBE NEWSWIRE) -- HealthEquity , Inc. ( [...]
Windtree Therapeutics Announces It Will Receive $7.5 Million In Cash and Securities from the Recently Executed Termination Agreement with an Environmental Services Company
13/11/2025
Windtree and TESI signed a letter of intent for a combination of cash and securities of TESI to be paid to Windtree The companies were engaged in a potential environmental services deal for Windtree to acquire Titan [...]
Parents Say Teens are Checked Out and Need Mental Health Support, According to New Report
13/11/2025
National survey spotlights fears of tech overuse NEW YORK, Nov. 13, 2025 (GLOBE NEWSWIRE) -- A new report from BODA Therapy finds that more than 78% of parents say their teens would or might benefit from mental-health [...]
Nexalin Technology Appoints Carmi Masha Technologies Ltd. as Exclusive Distributor in Israel
13/11/2025
Appointment Follows Israeli Ministry of Health Approval for Nexalin’s Gen-2 SYNC Device HOUSTON, TX, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL) (the “Company” or “Nexalin”), the leader in [...]
Inventiva annonce les modalités définitives ainsi que l'extension de l'offre au public d'American Depositary Shares d'approximativement 150 millions de dollars
13/11/2025
Daix (France), New York City (New York, États-Unis), le 13 novembre 2025 – Inventiva (Euronext Paris et Nasdaq : IVA) (« Inventiva » ou la « Société »), société biopharmaceutique spécialisée dans le développement de [...]
Inventiva announces pricing of upsized public offering of approximately $150M of American Depositary Shares
13/11/2025
Daix (France), New York City (New York, United States), November 13, 2025 – Inventiva (Euronext Paris and Nasdaq: IVA) (" Inventiva " or the " Company "), a clinical-stage biopharmaceutical company focused on the [...]
U.S. Oral Surgery Management Secures New Partner Practices in Three States
13/11/2025
IRVING, Texas, Nov. 13, 2025 (GLOBE NEWSWIRE) -- U.S. Oral Surgery Management ( USOSM ) – a management services organization that exclusively serves premier oral and maxillofacial surgeons – has three new partner [...]
Zone School of Healing Celebrates Eight-Year Milestone as One of the Fastest-Growing Chiropractic & Healing Schools Worldwide
13/11/2025
FRANKLIN, Tenn., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Zone School of Healing is proudly celebrating over eight years of transformative growth and success, solidifying its position as one of the fastest-growing schools [...]
Inventiva annonce la reprise des négociations de ses actions ordinaires sur Euronext Paris
13/11/2025
Daix (France), New York City (New York, États-Unis), le 13 novembre 2025 – Inventiva (Euronext Paris et Nasdaq : IVA) (« Inventiva » ou la « Société »), société biopharmaceutique spécialisée dans le développement de [...]
Inventiva announces trading resumption of its ordinary shares on Euronext Paris
13/11/2025
Daix (France), New York City (New York, United States), November 13, 2025 – Inventiva (Euronext Paris and Nasdaq: IVA) (" Inventiva " or the " Company "), a clinical-stage biopharmaceutical company focused on the [...]
Legend Senior Living® Expands Presence to New Jersey, Welcoming Azalea of Cinnaminson
13/11/2025
WICHITA, Kan., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Legend Senior Living ® , a nationally recognized senior living provider based in Wichita, KS, has announced the management of Azalea of Cinnaminson. This marks the [...]
Kura Oncology and Kyowa Kirin Announce FDA Approval of KOMZIFTI™ (ziftomenib), the First and Only Once-Daily Targeted Therapy for Adults with Relapsed or Refractory NPM1-Mutated Acute Myeloid Leukemia
13/11/2025
– NPM1 mutations, one of the most common genetic drivers of AML, are now actionable for patients – – Acute unmet need in R/R NPM1 -mutated AML defined by historically poor outcomes and low survival rates at relapse – – [...]
Zealand Pharma Announces Financial Results for the First Nine Months of 2025
13/11/2025
Company announcement – No. 23 / 2025 Zealand Pharma Announces Financial Results for the First Nine Months of 2025 With petrelintide advancing at full speed and topline data rapidly approaching for both petrelintide and [...]
T-Therapeutics announces Series A extension to $91 million to advance first-in-class bispecifics towards the clinic
13/11/2025
$32 million new equity injection adds to previously announced $59 million New investors Tencent and BGF joined by all existing major shareholders Funds will advance pipeline of novel TCR-CD3 bispecifics in cancer and [...]
Enterome to present positive interim Phase 2 data for lead OncoMimics™ immunotherapy EO2463 in follicular lymphoma at American Society for Hematology (ASH) meeting
13/11/2025
New data from cohort 3 show EO2463 can be safely added to rituximab in first-line low-tumor-burden follicular lymphoma in need of treatment All six patients responded positively to the combination Overall response data [...]
Inventiva annonce la suspension temporaire du cours de ses actions ordinaires sur Euronext Paris
13/11/2025
Daix (France), New York City (New York, États-Unis), le 13 novembre 2025 – Inventiva (Euronext Paris et Nasdaq : IVA) (« Inventiva » ou la « Société »), société biopharmaceutique spécialisée dans le développement de [...]
Inventiva announces temporary trading halt of its ordinary shares on Euronext Paris
13/11/2025
Daix (France), New York City (New York, United States), November 13, 2025 – Inventiva (Euronext Paris and Nasdaq: IVA) (" Inventiva " or the " Company "), a clinical-stage biopharmaceutical company focused on the [...]

Pages